Zomedica GC Karen DeHaan-Fullerton Receives 250,000-Share Award

What Happened
Karen DeHaan-Fullerton, General Counsel of Zomedica Corp. (ZOMDF), was granted a derivative award of 250,000 shares (reported as an award/acquisition, code A) on 2026-08-05. The grant is reported at $0.00 per share (no cash paid at grant); these are options/award rights rather than immediately owned common shares.

Key Details

• Transaction date: 2026-08-05; Form 4 filed 2026-08-07 (timely filing).
• Transaction type/code: Award/Grant (A) of derivative securities.
• Amount: 250,000 shares (derivative/option award) reported at $0.00 per share.
• Shares owned after transaction: Not specified in the filing.
• Vesting/footnote: "One quarter (1/4) of the options to vest on the first anniversary of the date of grant and 1/48 to vest monthly thereafter until fully vested on 8/4/2030." (reported in the filing remarks/footnote).
• No indication of exercise or sale — this is a grant of an award, not a cash purchase or sale.

Context
This was a time‑based equity award (options/rights) to an officer. Such grants provide potential future upside if the stock appreciates, but they are subject to the stated vesting schedule and are not immediate share ownership or cash value. The filing shows the grant amount and vesting terms; it does not indicate any immediate exercise or sale.